Cutaneous T-cell Lymphoma - Relapsed/Refractory

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
20:07

SOHO Highlights: State of the Art and Next Questions

R/R PTCL State of the Art: Allo-SCT vs. Auto-SCT? Can Pralatrexate Change the Tumor Volume? Does Duvelisib+Romidepsin Increase ORR?

FEATURING Kerry Savage
  • 23 views
  • February 3, 2021
08:38

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO MAVORIC Update on R/R CTCL: What Is the Impact of Concomitant Steroids on Mogamulizumab Efficacy?

FEATURING Larisa Geskin
  • 167 views
  • December 15, 2020
  • 1
16:04

Xth Eurasian Hematology-Oncology Congress

St-Petersburg Hematological Centre Experience on the Use of BMT in Relapsed/Refractory Malignant Lymphomas: Brentuximab Vedotin is Safe and Effective as a Bridge Therapy and for Relapses after allo-HSC

FEATURING Natalia Mikhailova
  • 27 views
  • December 13, 2019
30:08

City of Hope

Advances in Therapy in Cutaneous T Cell Lymphoma

FEATURING Christiane Querfeld
  • 154 views
  • November 21, 2018
11:25

Jennifer Amengual

Results of the Phase 1 Study of Pralatrexate Plus Romidepsin: Highly Effective in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

  • 142 views
  • October 17, 2018
19:49

2018 Pan Pacific Lymphoma Conference

Cutaneous T-cell Lymphoma: Management of Transformed Mycosis Fungoides and Sezary Syndrome

FEATURING Youn H. Kim
  • 296 views
  • August 23, 2018
  • 3
17:03

Yale Cancer Center

Clinical Trials and Novel Therapies in Cutaneous T-cell Lymphoma

FEATURING Francine M Foss
  • 55 views
  • July 12, 2018
05:18

Yale Cancer Center

Current Treatment for CTCL

FEATURING Francine M Foss
  • 332 views
  • July 12, 2018
  • 1
06:12

Indy Hematology Review

New Approaches in DLBCL

FEATURING John Leonard
  • 475 views
  • April 12, 2018
05:28

Srdan Verstovsek

New Approaches to Patients with Lymphoma and (CLL) Chronic Lymphocytic Leukemia

  • 533 views
  • January 3, 2018
  • 1

Cutaneous T-cell Lymphoma - Relapsed/Refractory

No subtopics